Search results
-
ESMO 2024 – Incyte tries again in anal cancer
ESMO 2024 – Incyte tries again in anal cancer …
- 09/15/2024 - 08:35 -
Why Astra won’t find bladder cancer domination easy
… Toplined positive for EFS & OS Jun 2024; full data due at ESMO 2024 presidential session Nile 1L …
- 09/07/2024 - 17:40 -
ESMO 2024 preview – TIGIT gets its late-breaker
ESMO 2024 preview – TIGIT gets its late-breaker … the discontinuation of LOXO-783 . Selected ESMO 2024 late-breakers* Project Company …
- 09/09/2024 - 14:48 -
ESMO 2024 preview – presidential focus
ESMO 2024 preview – presidential focus … settings’ respective effects. Selected ESMO 2024 presidential presentations Project …
- 08/27/2024 - 16:15 -
Opdualag sets its sights on lung
… NSCLC Ph2 chemo combo, vs Opdivo + chemo, data at ESMO 2024 Relativity-069 2nd-line Hodgkin’s …
- 02/14/2025 - 11:24 -
Is this the end for MacroGenics’ vobra-duo?
… Ph2 Tamarack trial discontinued Jul 2024; more data due at ESMO 2024 Lorigerlimab Anti-PD-1 x CTLA-4 …
- 08/05/2024 - 12:30 -
ESMO 2024 preview – Summit and BioNTech battle again
ESMO 2024 preview – Summit and BioNTech battle again … NGM707 (which also hits ILT4). Selected ESMO 2024 oral presentations featuring biologicals …
- 07/24/2024 - 10:26 -
ESMO 2024 preview – Astellas unveils its KRAS degrader
ESMO 2024 preview – Astellas unveils its KRAS degrader … straight SMARCA2 inhibitor FHD-909 . Selected ESMO 2024 oral presentations on small-molecule approaches …
- 07/24/2024 - 17:44 -
ESMO 2024 preview – conjugates in the spotlight
ESMO 2024 preview – conjugates in the spotlight … hasn't yet yielded any clinical data. Selected ESMO 2024 oral presentations featuring ADCs …
- 07/23/2024 - 13:17
